The thinning of retinal layers detected with OCT could offer a view into progression independent of relapse activity, an ...

GLP-1 receptor agonists may reduce the likelihood of mortality and increase odds for transplant wait-listing for patients ...

Among women with asthma, elevated average fine particulate matter and nitrogen dioxide exposure over 48 months each raised ...

We all know that our health care system is in urgent need of transformation. Rather than addressing the root causes of ...

Deaths of patients hospitalized with sepsis who were deemed previously healthy often could not be prevented due to the ...

Apollo TMS Therapy delivers targeted stimulation to specific brain regions responsible for mood and emotional regulation.The ...

Patients with inflammatory bowel disease had a higher risk for venous thromboembolism after surgery for colorectal cancer ...

The MariTide trial evaluated once-monthly maridebart cafraglutide, a dual bispecific GLP-1 receptor agonist and glucose-dependent insulinotropic polypeptide (GIP) receptor antagonist, for the ...

The CATALYST trial evaluated mifepristone, a glucocorticoid receptor antagonist, for HbA1c lowering in adults with hypercortisolism and inadequately controlled type 2 diabetes.Read Healio’s in-depth ...

Patients with autoimmune conditions and chronic inflammation may be at twice the risk for mental health disorders such as ...

Health care professionals may prescribe GLP-1s for people with diabetes and binge eating disorder with strong psychotherapy support, a slow dose titration and close follow-up after initiation, ...

Among patients with obesity, semaglutide 7.2 mg reduced body weight by more than 18% for those without diabetes and by more than 13% for those with diabetes, according to the results of the STEP UP ...